Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2022-04-28 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
独立董事工作制度（2022年4月）
Governance Information Classification · 95% confidence The document is titled '独立董事工作制度' which translates to 'Independent Director Work System' and contains detailed governance rules and procedures related to the appointment, duties, rights, and obligations of independent directors within the company. It references relevant laws, stock exchange rules, and company bylaws. The content is focused on governance structure and internal rules rather than financial results, audit opinions, or shareholder meeting materials. It is a governance-related document outlining internal rules and practices for board members, specifically independent directors. Therefore, the document fits best under the category of Governance Information (CGR). The document length (7711 characters) and detailed content confirm it is a full governance report, not a brief announcement or a certification.
2022-04-28 Chinese
股东大会议事规则(2022年4月）
Governance Information Classification · 100% confidence The document is titled as the "Shareholders' Meeting Rules" of 盈康生命科技股份有限公司 (Yingkang Life Technology Co., Ltd.) dated April 2022. It extensively details the procedures, powers, and regulations governing the company's shareholders' meetings, including the convening, proposal submission, voting, and resolution processes. It does not contain financial statements, audit opinions, or earnings data. Instead, it is a governance document outlining internal rules and procedures related to shareholder meetings and corporate governance. Therefore, it fits the category of Governance Information (CGR). The document length is substantial and contains detailed governance rules, not just an announcement or summary, so it is not an RPA or RNS filing.
2022-04-28 Chinese
公司章程（2022年4月）
Governance Information Classification · 100% confidence The document is titled as the "Company Articles of Association" (公司章程) for 盈康生命科技股份有限公司, dated April 2022. It contains detailed provisions on company governance, shareholder rights, board structure, share issuance, share transfer, shareholder meetings, and other corporate governance matters. It references relevant laws and regulations such as the Company Law of China and securities regulations. The content is a comprehensive governance document outlining the internal rules and organizational structure of the company rather than a financial report, announcement, or meeting material. Therefore, it fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the governance document, not a brief announcement or summary.
2022-04-28 Chinese
关于2021年度计提信用减值损失及资产减值损失的公告
Audit Report / Information Classification · 95% confidence The document is an announcement by 盈康生命科技股份有限公司 regarding the 2021 fiscal year asset impairment and credit loss provisions. It details the accounting standards applied, the amounts of impairment for receivables and goodwill, and the impact on the company's financial results. The document includes specific financial figures and explanations of the impairment testing process, referencing accounting standards and an audit confirmation. The length is 3329 characters, which is relatively short but contains substantive financial data and detailed analysis of impairment losses, not merely an announcement of a report or a certification. It is not a full annual report (10-K) but a specific disclosure about asset impairment and credit loss provisions. This fits best under Audit Report / Information (AR), which covers standalone audit-related disclosures and accounting principle applications excluding full annual reports. Therefore, the classification is AR with high confidence. FY 2021
2022-04-28 Chinese
关于2021年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a special report on the storage and use of raised funds for the fiscal year 2021 by 盈康生命科技股份有限公司. It details the amount of funds raised, their usage, storage, management, and compliance with regulatory guidelines. The content focuses on the management and use of capital raised through a non-public stock issuance, including detailed financial figures and regulatory compliance references. This matches the description of a Capital/Financing Update, which covers updates on company fundraising and capital structure changes. The document is not an annual report or earnings release, nor is it a simple announcement or certification. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-04-28 Chinese
安信证券股份有限公司关于公司2021年内部控制评价报告的核查意见
Audit Report / Information Classification · 95% confidence The document is titled as a verification opinion on the 2021 internal control self-evaluation report of Yingkang Life Technology Co., Ltd. It is issued by Anxin Securities Co., Ltd., the sponsor institution, and contains detailed descriptions of the internal control evaluation scope, standards, findings, and the sponsor's verification work and opinion. The document focuses on internal control compliance and effectiveness, referencing regulatory rules and standards. It does not contain financial statements or quarterly/yearly financial results, nor is it a transcript, announcement of voting results, or a capital/financing update. It is a standalone audit-related verification report on internal controls, which fits the category of Audit Report / Information (AR). The document length is over 5,000 characters and contains substantive content, so it is not a mere announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2021
2022-04-28 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.